fbpx Skip to main content
 

Search

Janssen Search

Search results

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 30 OF 77

Pages

The Power of Precision: How J&J is Working to Deliver the Promise of Precision Medicine to Patients with Complex Disease   DNA Day on April 25 is an annual, global celebration of the discovery of the double helix structure of deoxyribonucleic acid ...

ZILI LI, M.D., M.P.H. HEAD OF ASIA PACIFIC R&D JANSSEN RESEARCH & DEVELOPMENT As Head of Asia Pacific R&D, Zili oversees all R&D activities within Asia Pacific, leading over 1,400 science professionals dedicated to delivering ...

New Grant to Harvard Medical School to Combat Drug-Resistant Tuberculosis As part of its ongoing commitment to global public health, Janssen entered into a novel collaboration with Harvard Medical School in Cambridge, Massachusetts, to address critical ...

Mar 26, 2024 United States FNAIT is a rare disease that occurs when a pregnant person’s immune system attacks fetal platelets, resulting in the risk of internal bleeding, which can be life threatening to the fetus or newborn The Phase 3 FREESIA program is ...

MYHEALTHAPPS.NET for Mobile Health Monitoring Janssen supported the launch of an international healthcare website called MYHEALTHAPPS.net. This website was developed to help patients and the public in finding relevant healthcare apps for smartphones that ...

Vaccines: The Heroes of Public Health This year’s World Immunization Week, themed, ‘ Protected Together: Vaccines Work! ’ celebrates ‘Vaccine Heroes’ from around the world. It gives us a moment to consider the significant leaps forward we have made as a ...

SARAH BRENNAN COMPANY GROUP CHAIRMAN GLOBAL COMMERCIAL STRATEGY ORGANIZATION Sarah Brennan is Company Group Chairman, Global Commercial Strategy Organization, for Johnson & Johnson Innovative Medicine. In this role, Sarah will be responsible for the ...

BEN WIEGAND, PH.D. GLOBAL HEAD WORLD WITHOUT DISEASE ACCELERATOR As Global Head of the World Without Disease Accelerator (WWDA), Ben Wiegand, Ph.D. leads a team focused on catalyzing a paradigm shift from disease care to health care through novel ...

Welcome, we're glad you're here! Our mission is to redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients. To get there, we need to push the boundaries of science and creativity – ...

Collaborations At Janssen R&D, we believe the best ideas can come from anywhere – which is why collaboration is at the heart of our Data Science and Digital Health efforts. Today, we have more than 35 active collaborations, with collaborators ranging ...

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 30 OF 77

Pages